Cargando…

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

Patients with triple-negative breast cancer (TNBC) have a considerably less favorable prognosis than those with hormone-positive breast cancers. TNBC patients do not respond to current endocrine treatment and have a 5-year survival prognosis of <30%. The research presented here is intended to fil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Rebecca, Sabnis, Nirupama, Sun, Xiangle, Ahluwalia, Ruhani, Lacko, Andras G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479299/ https://www.ncbi.nlm.nih.gov/pubmed/28670138 http://dx.doi.org/10.2147/BCTT.S131038

Ejemplares similares

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
por: Johnson, Rebecca, et al.
Publicado: (2013)

The SR-B1 Receptor as a Potential Target for Treating Glioblastoma
por: Berney, Ethan, et al.
Publicado: (2019)

Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
por: Mooberry, Linda K., et al.
Publicado: (2016)

Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
por: Sabnis, Sarika, et al.
Publicado: (2017)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles
por: Sabnis, Nirupama, et al.
Publicado: (2012)

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics
por: Cruz, Pedro M. R., et al.
Publicado: (2013)

Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles
por: Xiong, Fangyuan, et al.
Publicado: (2017)

Targeted Nanoparticles for Pediatric Leukemia Therapy
por: Basha, Riyaz, et al.
Publicado: (2014)

Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma
por: Sabnis, Nirupama, et al.
Publicado: (2013)

HDL as a drug and nucleic acid delivery vehicle
por: Lacko, Andras G., et al.
Publicado: (2015)

Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
por: Mancini, Patrizia, et al.
Publicado: (2014)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
por: Mezi, Silvia, et al.
Publicado: (2021)

The clinical promise of immunotherapy in triple-negative breast cancer
por: Vikas, Praveen, et al.
Publicado: (2018)

pH-Responsive Hyaluronic Acid Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy
por: Zeng, Xiangle, et al.
Publicado: (2022)

Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
por: Conniot, João, et al.
Publicado: (2014)

Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy
por: Dorniani, Dena, et al.
Publicado: (2016)

Multifunctional Graphene Oxide Nanodelivery Platform for Breast Cancer Treatment
por: Mo, Yousheng, et al.
Publicado: (2022)

Hyaluronic Acid-Mediated Phenolic Compound Nanodelivery for Cancer Therapy
por: Serini, Simona, et al.
Publicado: (2023)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021)

Nanodelivery of Dietary Polyphenols for Therapeutic Applications
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Nanodelivery of antiretroviral drugs to nervous tissues
por: Lawal, Sodiq Kolawole, et al.
Publicado: (2022)

Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer
por: Irimie, Alexandra Iulia, et al.
Publicado: (2017)

Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers
por: Ashique, Sumel, et al.
Publicado: (2023)

Triple-negative breast cancer: promising prognostic biomarkers currently in development
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent
por: Kura, Aminu Umar, et al.
Publicado: (2013)

Development of a liposomal nanodelivery system for nevirapine
por: Ramana, Lakshmi N, et al.
Publicado: (2010)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Nanodelivery of Natural Antioxidants: An Anti-aging Perspective
por: Vaiserman, Alexander, et al.
Publicado: (2020)

Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells
por: Patra, Arjun, et al.
Publicado: (2019)

Electromagnetic Field‐Programmed Magnetic Vortex Nanodelivery System for Efficacious Cancer Therapy
por: Liu, Xiaoli, et al.
Publicado: (2021)

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?
por: Cucinotto, Iole, et al.
Publicado: (2013)

Self-Assembled Nanodelivery System with Rapamycin and Curcumin for Combined Photo-Chemotherapy of Breast Cancer
por: Yin, Yanlong, et al.
Publicado: (2023)

Nanodelivery strategies for the treatment of multidrug‐resistant bacterial infections
por: Jiang, Lai, et al.
Publicado: (2018)

Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment
por: Hu, Yang, et al.
Publicado: (2020)

Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
por: Lim, Michael, et al.
Publicado: (2020)

Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
por: Imran, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iuovgjgse98e2v62s8o4nfqsvq